Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:lanostane
go back to main search page
Accession:CHEBI:20265 term browser browse the term
Definition:A triterpene that has formula C30H54.
Synonyms:related_synonym: (5alpha)-4,4,14-trimethylcholestane;   4,4,14-trimethylcholestane;   Formula=C30H54;   InChI=1S/C30H54/c1-21(2)11-9-12-22(3)23-15-19-30(8)25-13-14-26-27(4,5)17-10-18-28(26,6)24(25)16-20-29(23,30)7/h21-26H,9-20H2,1-8H3/t22-,23-,24+,25-,26+,28-,29-,30+/m1/s1;   InChIKey=ZQIOPEXWVBIZAV-ZKYCIREVSA-N;   SMILES=[H][C@@]1(CC[C@@]2(C)[C@]3([H])CC[C@@]4([H])C(C)(C)CCC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C;   [5S-[5alpha,8beta,9alpha,10beta,13beta,14alpha,17beta(S*)]]-17-(1,5-dimethylhexyl)hexadecahydro-4,4,10,13,14-pentamethyl-1H-cyclopenta[a]phenanthrene
 xref: Beilstein:3137145;   CAS:474-20-4



show annotations for term's descendants           Sort by:
14-demethyllanosterol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Msmo1 methylsterol monoxygenase 1 decreases abundance ISO MSMO1 protein results in decreased abundance of 4,4-dimethyl-5-alpha-cholesta-(8,24)-dien-3-beta-ol CTD PMID:23125191 NCBI chr 8:65,171,157...65,186,822
Ensembl chr 8:65,171,173...65,186,826
JBrowse link
24,25-dihydrolanosterol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp51 cytochrome P450, family 51 decreases abundance ISO CYP51A1 mRNA results in decreased abundance of lanostenol CTD PMID:23125191 NCBI chr 5:4,130,674...4,154,697
Ensembl chr 5:4,131,145...4,154,746
JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-Coenzyme A reductase decreases activity ISO lanostenol results in decreased activity of HMGCR protein CTD PMID:18024962 NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
JBrowse link
3beta-hydroxylanost-8-en-32-al term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Hmgcr 3-hydroxy-3-methylglutaryl-Coenzyme A reductase decreases activity EXP lanosten-3-ol-32-al results in decreased activity of HMGCR protein CTD PMID:12617470 NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
JBrowse link
cucurbitacin B term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Acta2 actin alpha 2, smooth muscle, aorta multiple interactions EXP cucurbitacin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA] CTD PMID:29250925 NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing decreases expression EXP cucurbitacin B results in decreased expression of ADIPOQ mRNA CTD PMID:24316209 NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
JBrowse link
G Bad BCL2-associated agonist of cell death increases expression
multiple interactions
ISO cucurbitacin B results in increased expression of BAD mRNA
[cucurbitacin B co-treated with Gefitinib] results in increased expression of BAD mRNA
CTD PMID:26183715 NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
JBrowse link
G Bak1 BCL2-antagonist/killer 1 increases expression
multiple interactions
ISO cucurbitacin B results in increased expression of BAK1 mRNA; cucurbitacin B results in increased expression of BAK1 protein
[cucurbitacin B co-treated with Gefitinib] results in increased expression of BAK1 mRNA; [cucurbitacin B co-treated with Gefitinib] results in increased expression of BAK1 protein
CTD PMID:26183715 NCBI chr17:27,238,786...27,247,601
Ensembl chr17:27,238,784...27,247,983
JBrowse link
G Bax BCL2-associated X protein multiple interactions
increases expression
EXP
ISO
cucurbitacin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of BAX mRNA]
[cucurbitacin B co-treated with Gefitinib] results in increased expression of BAX mRNA; [cucurbitacin B co-treated with Gefitinib] results in increased expression of BAX protein
cucurbitacin B results in increased expression of BAX mRNA; cucurbitacin B results in increased expression of BAX protein
CTD PMID:26183715 PMID:29250925 NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 multiple interactions
decreases expression
EXP
ISO
cucurbitacin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BCL2 mRNA]
cucurbitacin B results in decreased expression of BCL2 mRNA; cucurbitacin B results in decreased expression of BCL2 protein
[cucurbitacin B co-treated with Gefitinib] results in decreased expression of BCL2 mRNA; [cucurbitacin B co-treated with Gefitinib] results in decreased expression of BCL2 protein
CTD PMID:26183715 PMID:29250925 NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
JBrowse link
G Bcl2l1 BCL2-like 1 decreases expression
multiple interactions
ISO cucurbitacin B results in decreased expression of BCL2L1 mRNA
[cucurbitacin B co-treated with Gefitinib] results in decreased expression of BCL2L1 mRNA
CTD PMID:26183715 NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
JBrowse link
G Bcl2l11 BCL2 like 11 multiple interactions
increases expression
ISO [cucurbitacin B co-treated with Gefitinib] results in increased expression of BCL2L11 mRNA
cucurbitacin B results in increased expression of BCL2L11 mRNA
CTD PMID:26183715 NCBI chr 2:127,967,958...128,004,467
Ensembl chr 2:127,967,958...128,004,467
JBrowse link
G Casp3 caspase 3 increases cleavage
multiple interactions
ISO cucurbitacin B results in increased cleavage of CASP3 protein
[cucurbitacin B co-treated with Gefitinib] results in increased cleavage of CASP3 protein
CTD PMID:26183715 NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
JBrowse link
G Cat catalase multiple interactions EXP cucurbitacin B inhibits the reaction [Carbon Tetrachloride results in decreased activity of CAT protein] CTD PMID:29250925 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions EXP cucurbitacin B inhibits the reaction [Gefitinib results in increased expression of CCL2 mRNA] CTD PMID:33248157 NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
JBrowse link
G Ccnd1 cyclin D1 decreases expression
multiple interactions
EXP
ISO
cucurbitacin B results in decreased expression of CCND1
cucurbitacin B results in decreased expression of CCND1 mRNA; cucurbitacin B results in decreased expression of CCND1 protein
[cucurbitacin B co-treated with Gefitinib] results in decreased expression of CCND1 mRNA; [cucurbitacin B co-treated with Gefitinib] results in decreased expression of CCND1 protein
CTD PMID:24316209 PMID:26183715 NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
JBrowse link
G Cd36 CD36 molecule decreases expression EXP cucurbitacin B results in decreased expression of CD36 mRNA CTD PMID:24316209 NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
JBrowse link
G Cdkn1b cyclin dependent kinase inhibitor 1B increases expression
multiple interactions
ISO cucurbitacin B results in increased expression of CDKN1B protein
[cucurbitacin B co-treated with Gefitinib] results in increased expression of CDKN1B protein
CTD PMID:26183715 NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha decreases expression
multiple interactions
EXP cucurbitacin B results in decreased expression of CEBPA mRNA
STAT3 protein affects the reaction [cucurbitacin B results in decreased expression of CEBPA mRNA]
CTD PMID:24316209 NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353
JBrowse link
G Cebpd CCAAT/enhancer binding protein delta decreases expression EXP cucurbitacin B results in decreased expression of CEBPD CTD PMID:24316209 NCBI chr16:15,705,150...15,707,409
Ensembl chr16:15,705,150...15,708,895
JBrowse link
G Col1a1 collagen, type I, alpha 1 multiple interactions EXP cucurbitacin B inhibits the reaction [Carbon Tetrachloride results in increased expression of COL1A1 mRNA] CTD PMID:29250925 NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO [cucurbitacin B co-treated with Gefitinib] results in decreased phosphorylation of EGFR protein CTD PMID:26183715 NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
JBrowse link
G Fabp4 fatty acid binding protein 4, adipocyte decreases expression EXP cucurbitacin B results in decreased expression of FABP4 mRNA CTD PMID:24316209 NCBI chr 3:10,269,406...10,273,653
Ensembl chr 3:10,269,148...10,273,636
JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1, soluble multiple interactions EXP
ISO
cucurbitacin B inhibits the reaction [3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased expression of GOT1 protein]
cucurbitacin B inhibits the reaction [Lithocholic Acid results in increased expression of GOT1 protein]
CTD PMID:38104874 NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
JBrowse link
G Gpt glutamic pyruvic transaminase, soluble multiple interactions EXP
ISO
cucurbitacin B inhibits the reaction [3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased expression of GPT protein]
cucurbitacin B inhibits the reaction [Lithocholic Acid results in increased expression of GPT protein]
CTD PMID:38104874 NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
JBrowse link
G Hif1a hypoxia inducible factor 1, alpha subunit multiple interactions EXP
ISO
cucurbitacin B inhibits the reaction [3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased expression of HIF1A mRNA]; cucurbitacin B inhibits the reaction [3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased expression of HIF1A protein]
cucurbitacin B inhibits the reaction [Lithocholic Acid results in increased expression of HIF1A mRNA]; cucurbitacin B inhibits the reaction [Lithocholic Acid results in increased expression of HIF1A protein]
CTD PMID:38104874 NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP
ISO
cucurbitacin B inhibits the reaction [3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased secretion of IL1B protein]; cucurbitacin B inhibits the reaction [Carbon Tetrachloride results in increased expression of IL1B protein]
cucurbitacin B inhibits the reaction [Lithocholic Acid results in increased expression of IL1B mRNA]
CTD PMID:29250925 PMID:38104874 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
JBrowse link
G Il6 interleukin 6 multiple interactions ISO
EXP
cucurbitacin B inhibits the reaction [Lithocholic Acid results in increased expression of IL6 mRNA]; cucurbitacin B inhibits the reaction [Lithocholic Acid results in increased expression of IL6 protein]
cucurbitacin B inhibits the reaction [3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased expression of IL6 mRNA]; cucurbitacin B inhibits the reaction [3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased expression of IL6 protein]; cucurbitacin B inhibits the reaction [3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased secretion of IL6 protein]
CTD PMID:38104874 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
JBrowse link
G Klf5 Kruppel-like transcription factor 5 increases expression EXP cucurbitacin B results in increased expression of KLF5 CTD PMID:24316209 NCBI chr14:99,536,127...99,550,848
Ensembl chr14:99,536,127...99,552,472
JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions EXP cucurbitacin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MMP2 mRNA] CTD PMID:29250925 NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
JBrowse link
G Pparg peroxisome proliferator activated receptor gamma multiple interactions
decreases expression
EXP STAT3 protein affects the reaction [cucurbitacin B results in decreased expression of PPARG mRNA] CTD PMID:24316209 NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions
affects response to substance
decreases phosphorylation
EXP
ISO
[WP1066 results in decreased activity of STAT3 protein] which results in decreased susceptibility to cucurbitacin B; cucurbitacin B inhibits the reaction [3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased expression of STAT3 mRNA]; cucurbitacin B inhibits the reaction [3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased expression of STAT3 protein]; cucurbitacin B inhibits the reaction [Carbon Tetrachloride results in increased phosphorylation of STAT3 protein]; cucurbitacin B results in decreased phosphorylation of and results in decreased activity of STAT3 protein; STAT3 protein affects the reaction [cucurbitacin B results in decreased expression of CEBPA mRNA]; STAT3 protein affects the reaction [cucurbitacin B results in decreased expression of PPARG mRNA]
STAT3 protein affects the susceptibility to cucurbitacin B
[cucurbitacin B co-treated with Gefitinib] results in decreased phosphorylation of STAT3 protein; cucurbitacin B inhibits the reaction [Lithocholic Acid results in increased expression of and results in increased phosphorylation of STAT3 mRNA]
cucurbitacin B results in decreased phosphorylation of STAT3 protein
CTD PMID:24316209 PMID:26183715 PMID:29250925 PMID:38104874 NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions EXP cucurbitacin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA] CTD PMID:29250925 NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP
ISO
cucurbitacin B inhibits the reaction [3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased expression of TNF mRNA]; cucurbitacin B inhibits the reaction [3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased expression of TNF protein]; cucurbitacin B inhibits the reaction [3,5-diethoxycarbonyl-1,4-dihydrocollidine results in increased secretion of TNF protein]; cucurbitacin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein]
cucurbitacin B inhibits the reaction [Lithocholic Acid results in increased expression of TNF mRNA]; cucurbitacin B inhibits the reaction [Lithocholic Acid results in increased expression of TNF protein]
CTD PMID:29250925 PMID:38104874 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
JBrowse link
cycloartenol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cat catalase multiple interactions EXP cycloartenol inhibits the reaction [Benzoyl Peroxide results in decreased activity of CAT protein] CTD PMID:12804013 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
JBrowse link
G Cryz crystallin, zeta multiple interactions EXP cycloartenol inhibits the reaction [Benzoyl Peroxide results in decreased activity of CRYZ protein] CTD PMID:12804013 NCBI chr 3:154,302,348...154,328,819
Ensembl chr 3:154,302,348...154,328,819
JBrowse link
G G6pdx glucose-6-phosphate dehydrogenase X-linked multiple interactions EXP cycloartenol inhibits the reaction [Benzoyl Peroxide results in decreased activity of G6PD protein] CTD PMID:12804013 NCBI chr  X:73,453,089...73,472,486
Ensembl chr  X:73,453,089...73,472,800
JBrowse link
G Gsr glutathione reductase multiple interactions EXP cycloartenol inhibits the reaction [Benzoyl Peroxide results in decreased activity of GSR protein] CTD PMID:12804013 NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
JBrowse link
G Odc1 ornithine decarboxylase, structural 1 multiple interactions EXP cycloartenol inhibits the reaction [Benzoyl Peroxide results in increased activity of ODC1 protein] CTD PMID:12804013 NCBI chr12:17,594,906...17,601,503
Ensembl chr12:17,594,795...17,601,506
JBrowse link
G Xdh xanthine dehydrogenase multiple interactions EXP cycloartenol inhibits the reaction [Benzoyl Peroxide results in increased activity of XDH protein] CTD PMID:12804013 NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191
JBrowse link
ganoderol B term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ar androgen receptor multiple interactions ISO ganoderol B binds to and results in decreased activity of AR protein; ganoderol B inhibits the reaction [Dihydrotestosterone binds to AR protein] CTD PMID:17499997 NCBI chr  X:97,192,363...97,366,824
Ensembl chr  X:97,192,375...97,366,821
JBrowse link
G Srd5a1 steroid 5 alpha-reductase 1 decreases activity ISO ganoderol B results in decreased activity of SRD5A1 protein CTD PMID:17499997 NCBI chr13:69,721,568...69,759,611
Ensembl chr13:69,721,568...69,759,561
JBrowse link
lanost-8-ene-3beta,30-diol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Hmgcr 3-hydroxy-3-methylglutaryl-Coenzyme A reductase decreases activity EXP 32-hydroxy-24,25-dihydrolanosterol results in decreased activity of HMGCR protein CTD PMID:12617470 NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
JBrowse link
lanosterol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp27a1 cytochrome P450, family 27, subfamily a, polypeptide 1 increases metabolic processing ISO CYP27A1 protein results in increased metabolism of Lanosterol CTD PMID:14622972 NCBI chr 1:74,752,311...74,777,056
Ensembl chr 1:74,752,733...74,777,051
JBrowse link
G Cyp51 cytochrome P450, family 51 multiple interactions ISO [Ketoconazole results in increased activity of CYP51 protein] which results in increased abundance of Lanosterol
CYP51A1 gene inhibits the reaction [Fluconazole results in decreased metabolism of and results in increased abundance of Lanosterol]; CYP51A1 gene inhibits the reaction [Itraconazole results in decreased metabolism of and results in increased abundance of Lanosterol]; CYP51A1 gene inhibits the reaction [Ketoconazole results in decreased metabolism of and results in increased abundance of Lanosterol]; CYP51A1 gene inhibits the reaction [Voriconazole results in decreased metabolism of and results in increased abundance of Lanosterol]
CTD PMID:12617470 PMID:18694951 NCBI chr 5:4,130,674...4,154,697
Ensembl chr 5:4,131,145...4,154,746
JBrowse link
G Ephx1 epoxide hydrolase 1, microsomal multiple interactions EXP Lanosterol analog inhibits the reaction [EPHX1 protein results in increased metabolism of cholesterol alpha-oxide] CTD PMID:2043152 NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
JBrowse link
G Ephx2 epoxide hydrolase 2, cytoplasmic multiple interactions EXP Lanosterol analog inhibits the reaction [EPHX2 protein results in increased metabolism of stilbene oxide analog] CTD PMID:2043152 NCBI chr14:66,321,821...66,361,971
Ensembl chr14:66,321,823...66,361,949
JBrowse link
G Marchf6 membrane associated ring-CH-type finger 6 increases stability ISO Lanosterol results in increased stability of MARCHF6 protein CTD PMID:30545937 NCBI chr15:31,456,045...31,531,172
Ensembl chr15:31,456,037...31,531,199
JBrowse link
G Nr1h5 nuclear receptor subfamily 1, group H, member 5 increases activity EXP Lanosterol results in increased activity of NR1H5 protein CTD PMID:17567710 NCBI chr 3:102,846,974...102,871,607
Ensembl chr 3:102,846,974...102,871,449
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 22340
    chemical entity 22339
      atom 22335
        nonmetal atom 22167
          carbon atom 21959
            organic molecular entity 21959
              organic fundamental parent 20341
                natural product fundamental parent 15240
                  terpenoid fundamental parent 4016
                    lanostane 45
                      (24R)-24-methylcycloart-25-en-3beta-ol 0
                      25-hydroxy-3-epidehydrotumulosic acid 0
                      3beta-hydroxy-9beta-9,19-cyclolanost-24-en-28-oic acid 0
                      3beta-hydroxylanost-8-en-32-al 1
                      4alpha-hydroxymethyl-4beta-methylzymosterol 0
                      4beta-methylzymosterol-4-carbaldehyde 0
                      9beta-9,19-cyclolanost-24-ene-3beta,28-diol + 0
                      colossolactone V 0
                      colossolactone VIII 0
                      cucurbitacin B + 30
                      cucurbitacin D 0
                      cycloartane + 0
                      cycloartenol + 6
                      dehydroeburiconic acid 0
                      fomitopinic acid A 0
                      fomitoside E 0
                      fomitoside F 0
                      ganoderol B 2
                      ganoderone A 0
                      ganoderone C 0
                      ganolucidic acid D 0
                      holothurin A3 acid 0
                      holothurin A4 acid 0
                      lanost-8-ene-3beta,30-diol 1
                      lanosta-9(11),24-dien-3-one 0
                      lanostane derivative + 0
                      lanosterol + 8
                      lucialdehyde B 0
                      lucialdehyde C 0
                      mollisoside A 0
                      neothyonidioside 0
                      parkeol 0
                      sclerodol B 0
                      stichloroside C1 0
                      suberosol 0
                      tsugarioside C 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 22340
    subatomic particle 22335
      composite particle 22335
        hadron 22335
          baryon 22335
            nucleon 22335
              atomic nucleus 22335
                atom 22335
                  main group element atom 22218
                    main group molecular entity 22218
                      s-block molecular entity 21834
                        hydrogen molecular entity 21751
                          hydrides 20799
                            organic hydride 20341
                              organic fundamental parent 20341
                                hydrocarbon 19922
                                  terpene 14781
                                    triterpene 1250
                                      lanostane 45
                                        (24R)-24-methylcycloart-25-en-3beta-ol 0
                                        25-hydroxy-3-epidehydrotumulosic acid 0
                                        3beta-hydroxy-9beta-9,19-cyclolanost-24-en-28-oic acid 0
                                        3beta-hydroxylanost-8-en-32-al 1
                                        4alpha-hydroxymethyl-4beta-methylzymosterol 0
                                        4beta-methylzymosterol-4-carbaldehyde 0
                                        9beta-9,19-cyclolanost-24-ene-3beta,28-diol + 0
                                        colossolactone V 0
                                        colossolactone VIII 0
                                        cucurbitacin B + 30
                                        cucurbitacin D 0
                                        cycloartane + 0
                                        cycloartenol + 6
                                        dehydroeburiconic acid 0
                                        fomitopinic acid A 0
                                        fomitoside E 0
                                        fomitoside F 0
                                        ganoderol B 2
                                        ganoderone A 0
                                        ganoderone C 0
                                        ganolucidic acid D 0
                                        holothurin A3 acid 0
                                        holothurin A4 acid 0
                                        lanost-8-ene-3beta,30-diol 1
                                        lanosta-9(11),24-dien-3-one 0
                                        lanostane derivative + 0
                                        lanosterol + 8
                                        lucialdehyde B 0
                                        lucialdehyde C 0
                                        mollisoside A 0
                                        neothyonidioside 0
                                        parkeol 0
                                        sclerodol B 0
                                        stichloroside C1 0
                                        suberosol 0
                                        tsugarioside C 0
paths to the root